b5e9b1f2a6de6292c492e13234f6acc7  303844.pdf
e18ca96fae70186f0b632c86f2969bcfa8f4d385  303844.pdf
7b2de6c374017f8b5762ccd9c2144b28f751e99dd9218ec1ea3efe322d418226  303844.pdf

Title:           Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2
Subject:         Clinical Lung Cancer, 24 (2023) 376-380. doi:10.1016/j.cllc.2023.02.002
Keywords:        "Adjuvant"; "Early-stage"; "Resectable"; "Tyrosine kinase inhibitor"; "Targeted therapy"
Author:          Yasuhiro Tsutani
Creator:         Elsevier
Producer:        Acrobat Distiller 10.0.0 (Windows)
CreationDate:    Mon May  8 22:47:50 2023 CEST
ModDate:         Mon May  8 22:48:07 2023 CEST
Custom Metadata: yes
Metadata Stream: yes
Tagged:          yes
UserProperties:  no
Suspects:        no
Form:            none
JavaScript:      no
Pages:           5
Encrypted:       no
Page size:       594 x 783 pts
Page rot:        0
File size:       566836 bytes
Optimized:       yes
PDF version:     1.7


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
PCCJKO+FuturaStd-CondensedLight      Type 1C           Custom           yes yes yes    687  0
PCCJEM+HelveticaLTStd-Light          Type 1C           Custom           yes yes yes    692  0
PCCJEK+MTSY                          Type 1C           Custom           yes yes yes    697  0
PCCJDJ+HelveticaLTStd-Bold           Type 1C           Custom           yes yes yes    702  0
PCCJKN+FuturaStd-Condensed           Type 1C           Custom           yes yes yes    707  0
PCCJDK+HelveticaLTStd-Roman          Type 1C           Custom           yes yes yes    712  0
PCCIKJ+HelveticaNeueLTStd-BdEx       Type 1C           Custom           yes yes yes    717  0
PCCJBJ+AGaramond-Regular             Type 1C           Custom           yes yes no     722  0
PCCJEL+HelveticaLTStd-Obl            Type 1C           Custom           yes yes yes    726  0
PCCJKM+Futura-DemiBold               Type 1C           Custom           yes yes yes    731  0
PCCJIM+RMTMI                         Type 1C           Custom           yes yes yes    736  0
PCCIKK+dummy-space                   Type 1C           WinAnsi          yes yes no     741  0
PCCKEM+FuturaStd-CondensedBold       Type 1C           Custom           yes yes yes    105  0
PCCJLP+AGaramond-BoldItalic          Type 1C           WinAnsi          yes yes no     110  0
PCCKFO+HelveticaLTStd-BoldCond       Type 1C           Custom           yes yes yes    113  0
PCCKFP+HelveticaLTStd-LightCond      Type 1C           Custom           yes yes yes     29  0
PCCKGA+TimesNewRomanPSMT-20          Type 1C           Custom           yes yes yes     34  0
PCCKEN+AGaramond-Bold                Type 1C           WinAnsi          yes yes no     118  0
PCCLLI+CMSY10                        Type 1C           Custom           yes yes yes     52  0
PCCMNC+AGaramond-Italic              Type 1C           WinAnsi          yes yes no      66  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2024-12-04 02:48:27 CET
 RepresentationInformation: 303844.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2024-12-03 10:18:13 CET
  Size: 566836
  Format: PDF
  Version: 1.7
  Status: Well-Formed, but not valid
  SignatureMatches:
   PDF-hul
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn1' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: Invalid indirect destination - referenced object 'tb2fn1' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: Invalid indirect destination - referenced object 'tb1fn2' cannot be found
   ID: PDF-HUL-149
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn2' cannot be found
   ID: PDF-HUL-122
   Offset: 507363
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb1fn1' cannot be found
   ID: PDF-HUL-122
   Offset: 507363
  ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'tb2fn1' cannot be found
   ID: PDF-HUL-122
   Offset: 507363
  MIMEtype: application/pdf
  Profile: Linearized PDF, Tagged PDF
  PDFMetadata: 
   Objects: 794
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    ViewerPreferences: 
     HideToolbar: false
     HideMenubar: false
     HideWindowUI: false
     FitWindow: false
     CenterWindow: false
     DisplayDocTitle: true
     NonFullScreenPageMode: UseNone
     Direction: L2R
     ViewArea: CropBox
     ViewClip: CropBox
     PrintArea: CropBox
     PageClip: CropBox
    PageLayout: SinglePage
    PageMode: UseOutlines
    Language: English
    Outlines: 
     Item: 
      Title: Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2
      Destination: chapter..1
      Children: 
       Item: 
        Title: Introduction
        Destination: section..1
       Item: 
        Title: Patients and Methods
        Destination: section..2
        Children: 
         Item: 
          Title: Objectives
          Destination: subsection..2.1
         Item: 
          Title: Key Eligibility Criteria
          Destination: subsection..2.2
         Item: 
          Title: Study Design
          Destination: subsection..2.3
         Item: 
          Title: Statistical Analysis
          Destination: subsection..2.4
       Item: 
        Title: Discussion
        Destination: section..3
       Item: 
        Title: Conclusion
        Destination: section..4
       Item: 
        Title: Disclosure
        Destination: section..5
       Item: 
        Title: CRediT authorship contribution statement
        Destination: section..6
       Item: 
        Title: Acknowledgments
        Destination: section..7
       Item: 
        Title: References
        Destination: section..8
   Info: 
    Title: Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2
    Author: Yasuhiro Tsutani
    Subject: Clinical Lung Cancer, 24 (2023) 376-380. doi:10.1016/j.cllc.2023.02.002
    Keywords: "Adjuvant"; "Early-stage"; "Resectable"; "Tyrosine kinase inhibitor"; "Targeted therapy"
    Creator: Elsevier
    Producer: Acrobat Distiller 10.0.0 (Windows)
    CreationDate: Mon May 08 23:17:50 CEST 2023
    ModDate: Mon May 08 23:18:07 CEST 2023
   ID: 0x4f010e13d792b7eda27970354d4ccfd8, 0x2a1f04a38f55a0be6db429800dc0e49e
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: PCCJIM+RMTMI
      FontSubset: true
      FirstChar: 60
      LastChar: 62
      FontDescriptor: 
       FontName: PCCJIM+RMTMI
       Flags: Symbolic, Italic
       FontBBox: 0, -213, 987, 680
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCKGA+TimesNewRomanPSMT-20
      FontSubset: true
      FirstChar: 3
      LastChar: 128
      FontDescriptor: 
       FontName: PCCKGA+TimesNewRomanPSMT-20
       Flags: Symbolic
       FontBBox: -210, -216, 1066, 865
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCMNC+AGaramond-Italic
      FontSubset: true
      FirstChar: 65
      LastChar: 120
      FontDescriptor: 
       FontName: PCCMNC+AGaramond-Italic
       Flags: Serif, Nonsymbolic, Italic
       FontBBox: -182, -285, 1150, 851
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: PCCJKN+FuturaStd-Condensed
      FontSubset: true
      FirstChar: 67
      LastChar: 117
      FontDescriptor: 
       FontName: PCCJKN+FuturaStd-Condensed
       Flags: Symbolic
       FontBBox: -157, -216, 894, 969
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCIKK+dummy-space
      FontSubset: true
      FirstChar: 32
      LastChar: 32
      FontDescriptor: 
       FontName: PCCIKK+dummy-space
       Flags: Nonsymbolic
       FontBBox: 0, 0, 0, 0
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: PCCJDK+HelveticaLTStd-Roman
      FontSubset: true
      FirstChar: 37
      LastChar: 147
      FontDescriptor: 
       FontName: PCCJDK+HelveticaLTStd-Roman
       Flags: Symbolic
       FontBBox: -166, -225, 1000, 931
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCKEM+FuturaStd-CondensedBold
      FontSubset: true
      FirstChar: 48
      LastChar: 57
      FontDescriptor: 
       FontName: PCCKEM+FuturaStd-CondensedBold
       Flags: Symbolic, ForceBold
       FontBBox: -140, -261, 1195, 990
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCIKJ+HelveticaNeueLTStd-BdEx
      FontSubset: true
      FirstChar: 65
      LastChar: 119
      FontDescriptor: 
       FontName: PCCIKJ+HelveticaNeueLTStd-BdEx
       Flags: Symbolic, ForceBold
       FontBBox: -145, -213, 1163, 984
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCJLP+AGaramond-BoldItalic
      FontSubset: true
      FirstChar: 65
      LastChar: 121
      FontDescriptor: 
       FontName: PCCJLP+AGaramond-BoldItalic
       Flags: Serif, Nonsymbolic, Italic, ForceBold
       FontBBox: -183, -285, 1166, 862
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: PCCJKO+FuturaStd-CondensedLight
      FontSubset: true
      FirstChar: 36
      LastChar: 169
      FontDescriptor: 
       FontName: PCCJKO+FuturaStd-CondensedLight
       Flags: Symbolic
       FontBBox: -125, -221, 896, 961
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCKFO+HelveticaLTStd-BoldCond
      FontSubset: true
      FirstChar: 49
      LastChar: 121
      FontDescriptor: 
       FontName: PCCKFO+HelveticaLTStd-BoldCond
       Flags: Symbolic, ForceBold
       FontBBox: -169, -250, 1091, 991
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCJBJ+AGaramond-Regular
      FontSubset: true
      FirstChar: 30
      LastChar: 174
      FontDescriptor: 
       FontName: PCCJBJ+AGaramond-Regular
       Flags: Serif, Nonsymbolic
       FontBBox: -183, -269, 1099, 851
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: PCCJEM+HelveticaLTStd-Light
      FontSubset: true
      FirstChar: 40
      LastChar: 169
      FontDescriptor: 
       FontName: PCCJEM+HelveticaLTStd-Light
       Flags: Symbolic
       FontBBox: -164, -250, 1000, 979
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCLLI+CMSY10
      FontSubset: true
      FirstChar: 129
      LastChar: 129
      FontDescriptor: 
       FontName: PCCLLI+CMSY10
       Flags: Symbolic, Italic
       FontBBox: -29, -960, 1116, 775
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCJEL+HelveticaLTStd-Obl
      FontSubset: true
      FirstChar: 44
      LastChar: 117
      FontDescriptor: 
       FontName: PCCJEL+HelveticaLTStd-Obl
       Flags: Symbolic, Italic
       FontBBox: -170, -225, 1116, 931
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCKEN+AGaramond-Bold
      FontSubset: true
      FirstChar: 45
      LastChar: 150
      FontDescriptor: 
       FontName: PCCKEN+AGaramond-Bold
       Flags: Serif, Nonsymbolic, ForceBold
       FontBBox: -158, -269, 1147, 862
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: PCCJEK+MTSY
      FontSubset: true
      FirstChar: 2
      LastChar: 61
      FontDescriptor: 
       FontName: PCCJEK+MTSY
       Flags: Symbolic
       FontBBox: 0, -954, 1043, 796
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCJKM+Futura-DemiBold
      FontSubset: true
      FirstChar: 51
      LastChar: 55
      FontDescriptor: 
       FontName: PCCJKM+Futura-DemiBold
       Flags: Symbolic
       FontBBox: -153, -250, 1139, 930
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCKFP+HelveticaLTStd-LightCond
      FontSubset: true
      FirstChar: 37
      LastChar: 147
      FontDescriptor: 
       FontName: PCCKFP+HelveticaLTStd-LightCond
       Flags: Symbolic
       FontBBox: -170, -250, 1000, 986
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: PCCJDJ+HelveticaLTStd-Bold
      FontSubset: true
      FirstChar: 58
      LastChar: 121
      FontDescriptor: 
       FontName: PCCJDJ+HelveticaLTStd-Bold
       Flags: Symbolic, ForceBold
       FontBBox: -170, -228, 1003, 962
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="XMP Core 5.1.2">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/">
         <xmp:CreateDate>2023-05-09T02:17:50+05:30</xmp:CreateDate>
         <xmp:CreatorTool>Elsevier</xmp:CreatorTool>
         <xmp:ModifyDate>2023-05-09T02:18:07+05:30</xmp:ModifyDate>
         <xmp:MetadataDate>2023-05-09T02:18:07+05:30</xmp:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Producer>Acrobat Distiller 10.0.0 (Windows)</pdf:Producer>
         <pdf:Keywords>"Adjuvant"; "Early-stage"; "Resectable"; "Tyrosine kinase inhibitor"; "Targeted therapy"</pdf:Keywords>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>doi:10.1016/j.cllc.2023.02.002</dc:identifier>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>Elsevier Inc.</rdf:li>
            </rdf:Bag>
         </dc:publisher>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Clinical Lung Cancer, 24 (2023) 376-380. doi:10.1016/j.cllc.2023.02.002</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:subject>
            <rdf:Bag>
               <rdf:li>Adjuvant</rdf:li>
               <rdf:li>Early-stage</rdf:li>
               <rdf:li>Resectable</rdf:li>
               <rdf:li>Tyrosine kinase inhibitor</rdf:li>
               <rdf:li>Targeted therapy</rdf:li>
            </rdf:Bag>
         </dc:subject>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Yasuhiro Tsutani</rdf:li>
               <rdf:li>Jonathan W. Goldman</rdf:li>
               <rdf:li>Sanja Dacic</rdf:li>
               <rdf:li>Yasushi Yatabe</rdf:li>
               <rdf:li>Margarita Majem</rdf:li>
               <rdf:li>Xiangning Huang</rdf:li>
               <rdf:li>Allen Chen</rdf:li>
               <rdf:li>Toon van der Gronde</rdf:li>
               <rdf:li>Jie He</rdf:li>
            </rdf:Seq>
         </dc:creator>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
         <xmpMM:DocumentID>uuid:fd8cfc10-4791-4a8b-8025-00abb91efa0c</xmpMM:DocumentID>
         <xmpMM:InstanceID>uuid:468e461e-ad41-4620-be3f-f2a785336739</xmpMM:InstanceID>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/">
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:copyright>© 2023 The Authors. Published by Elsevier Inc.</prism:copyright>
         <prism:publicationName>Clinical Lung Cancer</prism:publicationName>
         <prism:issn>1525-7304</prism:issn>
         <prism:volume>24</prism:volume>
         <prism:number>4</prism:number>
         <prism:doi>10.1016/j.cllc.2023.02.002</prism:doi>
         <prism:url>https://doi.org/10.1016/j.cllc.2023.02.002</prism:url>
         <prism:startingPage>376</prism:startingPage>
         <prism:endingPage>380</prism:endingPage>
         <prism:pageRange>376-380</prism:pageRange>
         <prism:coverDisplayDate>June 2023</prism:coverDisplayDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <pdfx:ElsevierWebPDFSpecifications>7.0</pdfx:ElsevierWebPDFSpecifications>
         <pdfx:CrossmarkMajorVersionDate>2010-04-23</pdfx:CrossmarkMajorVersionDate>
         <pdfx:CrossmarkDomainExclusive>true</pdfx:CrossmarkDomainExclusive>
         <pdfx:doi>10.1016/j.cllc.2023.02.002</pdfx:doi>
         <pdfx:robots>noindex</pdfx:robots>
         <pdfx:AuthoritativeDomain>
            <rdf:Bag>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Bag>
         </pdfx:AuthoritativeDomain>
         <pdfx:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Seq>
         </pdfx:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:jav="http://www.niso.org/schemas/jav/1.0/">
         <jav:journal_article_version>VoR</jav:journal_article_version>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:crossmark_1_="http://crossref.org/crossmark/1.0/">
         <crossmark_1_:CrossmarkDomainExclusive>true</crossmark_1_:CrossmarkDomainExclusive>
         <crossmark_1_:MajorVersionDate>2010-04-23</crossmark_1_:MajorVersionDate>
         <crossmark_1_:DOI>10.1016/j.cllc.2023.02.002</crossmark_1_:DOI>
         <crossmark_1_:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>sciencedirect.com</rdf:li>
               <rdf:li>elsevier.com</rdf:li>
            </rdf:Seq>
         </crossmark_1_:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmpRights="http://ns.adobe.com/xap/1.0/rights/">
         <xmpRights:Marked>True</xmpRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:ali="http://www.niso.org/schemas/ali/1.0/">
         <ali:license_ref>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ali:uri>http://creativecommons.org/licenses/by-nc-nd/4.0/</ali:uri>
               </rdf:li>
            </rdf:Bag>
         </ali:license_ref>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 376
     Sequence: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 460, 719, 541, 731
      Annotation: 
       Subtype: Link
       Rect: 185, 603, 192, 621
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 328, 603, 336, 621
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 408, 603, 416, 621
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 504, 603, 512, 621
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 160, 586, 167, 604
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 275, 586, 283, 604
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 353, 586, 361, 604
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 489, 586, 497, 604
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 533, 586, 541, 604
       Destination: 674
      Annotation: 
       Subtype: Link
       Rect: 323, 336, 527, 348
      Annotation: 
       Subtype: Link
       Rect: 246, 266, 252, 277
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 252, 266, 257, 277
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 98, 72, 154, 81
      Annotation: 
       Subtype: Link
       Rect: 533, 291, 539, 302
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 319, 255, 329, 267
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 351, 219, 356, 231
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 356, 219, 362, 231
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 425, 207, 430, 219
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 403, 160, 408, 171
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 474, 112, 480, 123
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 480, 112, 488, 123
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 536, 76, 541, 87
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 411, 37, 539, 47
      Annotation: 
       Subtype: Link
       Rect: 430, 27, 541, 37
    Page: 
     Label: 377
     Sequence: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 165, 677, 174, 689
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 218, 594, 234, 605
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 268, 534, 276, 545
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 73, 486, 82, 498
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 108, 426, 116, 438
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 180, 403, 188, 414
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 188, 403, 197, 414
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 197, 403, 205, 414
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 221, 241, 249, 252
       Destination: 27
      Annotation: 
       Subtype: Link
       Rect: 255, 198, 286, 210
       Destination: 27
      Annotation: 
       Subtype: Link
       Rect: 212, 138, 220, 150
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 398, 701, 430, 712
       Destination: 46
      Annotation: 
       Subtype: Link
       Rect: 451, 581, 460, 592
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 369, 509, 397, 521
       Destination: 27
      Annotation: 
       Subtype: Link
       Rect: 371, 246, 377, 257
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 377, 246, 382, 257
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 323, 210, 331, 222
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 489, 198, 497, 210
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 415, 186, 424, 198
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 333, 127, 338, 138
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 338, 127, 347, 138
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 335, 79, 343, 90
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 343, 79, 352, 90
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 447, 67, 456, 78
       Destination: 64
    Page: 
     Label: 378
     Sequence: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 170, 688, 175, 699
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 450, 534, 456, 545
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 191, 346, 195, 356
       Destination: null
      Annotation: 
       Subtype: Link
       Rect: 68, 98, 77, 109
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 77, 98, 85, 109
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 282, 74, 290, 85
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 398, 146, 406, 157
       Destination: 64
    Page: 
     Label: 379
     Sequence: 4
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 279, 390, 288, 401
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 220, 366, 236, 377
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 227, 330, 233, 341
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 279, 306, 288, 318
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 94, 270, 103, 282
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 103, 270, 111, 282
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 132, 234, 140, 246
       Destination: 64
    Page: 
     Label: 380
     Sequence: 5
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 58, 426, 115, 438
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 76, 380, 173, 387
      Annotation: 
       Subtype: Link
       Rect: 44, 335, 295, 355
      Annotation: 
       Subtype: Link
       Rect: 44, 319, 294, 339
      Annotation: 
       Subtype: Link
       Rect: 44, 295, 295, 323
      Annotation: 
       Subtype: Link
       Rect: 44, 272, 295, 299
      Annotation: 
       Subtype: Link
       Rect: 44, 248, 295, 275
      Annotation: 
       Subtype: Link
       Rect: 44, 224, 295, 251
      Annotation: 
       Subtype: Link
       Rect: 44, 200, 295, 227
      Annotation: 
       Subtype: Link
       Rect: 44, 176, 295, 203
      Annotation: 
       Subtype: Link
       Rect: 44, 152, 295, 179
      Annotation: 
       Subtype: Link
       Rect: 44, 128, 295, 155
      Annotation: 
       Subtype: Link
       Rect: 317, 710, 562, 738
      Annotation: 
       Subtype: Link
       Rect: 317, 686, 562, 714
      Annotation: 
       Subtype: Link
       Rect: 317, 662, 562, 690
      Annotation: 
       Subtype: Link
       Rect: 317, 647, 562, 666
      Annotation: 
       Subtype: Link
       Rect: 317, 615, 562, 650
      Annotation: 
       Subtype: Link
       Rect: 317, 591, 562, 618
      Annotation: 
       Subtype: Link
       Rect: 317, 567, 562, 594
      Annotation: 
       Subtype: Link
       Rect: 317, 551, 562, 570
      Annotation: 
       Subtype: Link
       Rect: 317, 520, 562, 540
      Annotation: 
       Subtype: Link
       Rect: 317, 479, 562, 507
      Annotation: 
       Subtype: Link
       Rect: 317, 455, 562, 483
      Annotation: 
       Subtype: Link
       Rect: 317, 431, 562, 459
      Annotation: 
       Subtype: Link
       Rect: 317, 415, 562, 435
      Annotation: 
       Subtype: Link
       Rect: 317, 391, 562, 419
      Annotation: 
       Subtype: Link
       Rect: 317, 376, 562, 395
      Annotation: 
       Subtype: Link
       Rect: 317, 352, 562, 379
      Annotation: 
       Subtype: Link
       Rect: 317, 329, 562, 349
      Annotation: 
       Subtype: Link
       Rect: 317, 312, 562, 331
      Annotation: 
       Subtype: Link
       Rect: 317, 288, 562, 315
      Annotation: 
       Subtype: Link
       Rect: 317, 256, 562, 291
      Annotation: 
       Subtype: Link
       Rect: 317, 232, 562, 260
      Annotation: 
       Subtype: Link
       Rect: 317, 192, 562, 236
      Annotation: 
       Subtype: Link
       Rect: 317, 168, 562, 196
      Annotation: 
       Subtype: Link
       Rect: 317, 152, 562, 172
  Checksum: 21e4275e
   Type: CRC32
  Checksum: b5e9b1f2a6de6292c492e13234f6acc7
   Type: MD5
  Checksum: e18ca96fae70186f0b632c86f2969bcfa8f4d385
   Type: SHA-1
  Checksum: 7b2de6c374017f8b5762ccd9c2144b28f751e99dd9218ec1ea3efe322d418226
   Type: SHA-256